October 2009
This list of corporate research fronts from
Essential Science IndicatorsSM
is from the second bimonthly period of 2009, and covers areas in the
biological sciences. Source dates are May 31, 2003-April 30, 2009
(sliding 6-year period).
|
Research
Front Name
|
Percentage of corporate affiliations
|
Leading
corporation
|
|
DRUG DISCOVERY USING HIGH-RESOLUTION LIQUID
CHROMATOGRAPHY/QUADRUPOLE TIME-OF-FLIGHT MASS
SPECTROMETRY
|
45
|
Waters Corp
|
|
IMPROVED PROTEIN-LIGAND DOCKING; EVALUATING VIRTUAL
SCREENING METHODS
|
34
|
Schrodinger, LLC
|
|
INADEQUATELY CONTROLLED TYPE 2 DIABETES MELLITUS; TYPE
2 DIABETES FAILING THIAZOLIDINEDIONE MONOTHERAPY
|
25
|
Amylin Pharmaceuticals, Inc
|
|
HEPATITIS C VIRUS SERINE PROTEASE INHIBITORS; POTENT
HEPATITIS C VIRUS POLYMERASE INHIBITOR
|
21
|
Boehringer Ingelheim
|
2003-2009_2
